A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions

Cholesterol

Interventions

DRUG

ezetimibe

ezetimibe 10 mg tablet. Duration of Treatment 31 Weeks.

DRUG

Comparator: Placebo (unspecified)

matching placebo tablet. Duration of Treatment 31 Weeks.

DRUG

simvastatin

simvastatin 20 mg tablet. Duration of Treatment 31 Weeks.